---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-25-000141"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2025-08-19T23:59:59+00:00"
generated_at: "2026-05-17T11:27:54.179520+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Medtronic Q1 revenue $8.58B (+4.8% organic); raises FY26 EPS; adds 2 directors, forms new committees

## Summary
- Q1 GAAP EPS $0.81; non-GAAP EPS $1.26 (+2%), revenue $8.58B, organic growth 4.8%.
- FY26 non-GAAP EPS guidance raised to $5.60-$5.66 from $5.50-$5.60; organic revenue growth ~5% reaffirmed.
- Cardiac Ablation Solutions revenue +50% on pulsed field ablation strength; US +72%.
- Board expanded to 13; John Groetelaars and William Jellison appointed as independent directors.
- New Growth and Operations committees formed; Investor Day planned for mid-2026; engagement with Elliott Management.

## SEC filing metadata
- accession: 0001613103-25-000141
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2025-08-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000141/0001613103-25-000141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000141/mdt-20250818.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-25-000141
- JSON: https://secwatch.observer/filing/0001613103-25-000141.json
- Plain text: https://secwatch.observer/filing/0001613103-25-000141.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.